Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jakob Grauslund1,2,3, Nis Andersen4, Jens Andresen4

  • 1Øjenafdeling E, Odense Universitetshospital.

Ugeskrift for Laeger
|September 26, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The risk of retinal vascular events in patients using semaglutide: a scoping review.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
Same author

The impact of coronary artery bypass grafting on the short- and long-term development and progression of diabetic retinopathy: A Danish national matched cohort study.

Acta ophthalmologica·2026
Same author

Diabetic Retinopathy in Parous Women With and Without Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study.

Diabetes care·2026
Same author

Time and person sensitive foundation model for disease prediction and risk stratification.

NPJ digital medicine·2026
Same author

Training and validation of an automated algorithm to differentiate no and minimal diabetic retinopathy from more severe stages in wide-field images.

Acta ophthalmologica·2026
Same author

Inflammatory biomarkers as prognostic tools for diabetic retinopathy progression: a prospective study.

Diabetes research and clinical practice·2026
This summary is machine-generated.

Diabetic retinopathy screening in Denmark uses individualized intervals to prevent vision loss. Treatment options for proliferative diabetic retinopathy and diabetic macular edema include laser therapy, intravitreal therapy, and vitrectomy.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Public Health

Background:

  • Diabetic retinopathy (DR) is a leading cause of blindness in diabetic patients.
  • Early detection and treatment of DR are crucial to prevent severe visual impairment.
  • National screening programs are essential for managing DR complications.

Purpose of the Study:

  • To review the current guidelines for screening diabetic retinopathy in Denmark.
  • To summarize the treatment modalities for proliferative diabetic retinopathy and diabetic macular edema.
  • To provide an overview of the national DR screening program in Denmark.

Main Methods:

  • Review of national guidelines for diabetic retinopathy screening and treatment in Denmark.
  • Summary of evidence-based practices for individualized screening intervals.

Related Experiment Videos

  • Compilation of current treatment options for advanced DR.

    • Main Results:

    • Denmark has a nationally implemented screening program for DR.
    • Individualized screening intervals are a key component of the Danish guidelines.
    • Treatment options encompass retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy.

    Conclusions:

    • The Danish national guidelines provide a framework for effective DR screening and management.
    • Individualized screening intervals aim to optimize early detection and intervention.
    • Timely treatment of proliferative DR and diabetic macular edema can preserve vision.